Table 1.
Mammal (human)
| ||||
Type | A4 Site | A3 Site | A2 Site | A1 Site |
α1(I) | 0% | 0% | 0% | 99% |
α2(I) | 0% | 80% | 0% | n/a |
α1(II) | 0% | 0% | 10-87% | 99% |
α1(III) | n/a | 0% | 0% | 0% |
α2(V) | 13% | 80% | 60% | 99% |
| ||||
Avian (chicken)
| ||||
Type | A4 Site | A3 Site | A2 Site | A1 Site |
α1(I) | n/a | 5-10% | 0% | 99% |
α2(I) | n/a | 95% | n/a | n/a |
α1(II) | 0% | 18% | 0% | 99% |
α1(III) | n/a | 0% | 0% | 100% |
α2(V) | 18% | 40% | 28% | 99% |
| ||||
Amphibian (xenopus)
| ||||
Type | A4 Site | A3 Site | A2 Site | A1 Site |
α1(I) | 0% | 12% | 0% | 99% |
α2(I) | n/a | n/a | n/a | n/a |
α1(II) | 0% | n/a | 0% | 99% |
α1(III) | n/a | 0% | 0% | 100% |
Molecular locations and abundance of 3Hyp sites within several vertebrates were identified using mass spectrometry. 3Hyp content was determined by scrolling the full scan to include all post-translational modification variations (n/a represents no substrate GPP in the known sequence). Note that only the A1 site is fully 3-hydroxylated across species.